José Paulo Martins

Universidade Federal Fluminense — Brazil

Immunology and Microbiology · Life Sciences

13h-index763citations28works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(7), Mesenchymal stem cell research(5), Cytomegalovirus and herpesvirus research(4), Immune Cell Function and Interaction(4), Hematopoietic Stem Cell Transplantation(3)

Publications28 total

STEM-10. TARGETING EPH FAMILY OF RECEPTORS: ADVANCED PRECISION THERAPY FOR GBM
Neuro-Oncology·2025
EXTH-76. Validating the Eph family of receptors as therapeutic targets using patient-derived Glioblastoma organoids
Neuro-Oncology·2025Open Access
Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis
Scientific Reports·2025· 1 citedOpen Access
EphA3 CAR T cells are effective against glioblastoma in preclinical models
Journal for ImmunoTherapy of Cancer·2024· 11 citedOpen Access
IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation
Journal of Clinical Investigation·2024· 8 citedOpen Access
Supplementary Table S1 from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Data from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Supplementary Table S1 from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Supplementary Figure S1 from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Data from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Supplementary Figure S1 from ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
2023Open Access
Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition
Blood·2021· 1 cited
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
Journal of Clinical Investigation·2020· 62 citedOpen Access
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome
Cancer Immunology Research·2020· 10 citedOpen Access
Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
Clinical & Translational Immunology·2020· 28 citedOpen Access
Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation
Science·2019· 65 cited
Dissecting the immunological determinants and consequences of cytomegalovirus reactivation in allogeneic haematopoietic stem cell transplantation using a novel murine model
2018
Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD
Clinical Cancer Research·2018· 23 cited
Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD
Bone Marrow Transplantation·2016· 3 citedOpen Access
What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
Stem Cells International·2015· 110 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Geoffrey R. Hill(12), Rachel D. Kuns(11), Antiopi Varelias(11), Siok‐Keen Tey(11), Mariapia A. Degli‐Esposti(11), Christopher E. Andoniou(10), Ping Zhang(9), Kate A. Markey(8), Kate H. Gartlan(8), Melody Cheong(8), Motoko Koyama(8), Mark J. Smyth(8), Slavica Vučković(8), Jason S. Lee(7), Karshing Chang(7), Vivien R. Sutton(7), Glen M. Boyle(7), Christian Engwerda(7), Kelli P. A. MacDonald(7), Joseph A. Trapani(7)